Imatinib
CMUH114-REC2-045
Phase 1 small_molecule active
Quick answer
Imatinib for Solid Tumor Cancer is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Solid Tumor Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active